Effect of paraaortic lymphadenectomy on 5-year survival in early stage cervical cancer

Aust N Z J Obstet Gynaecol. 1990 Nov;30(4):378-80. doi: 10.1111/j.1479-828x.1990.tb02035.x.

Abstract

This study includes 278 patients with Stages 1 and 2 cervical cancer subjected to type 3 hysterectomy and lymphadenectomy. The incidence of lymph node metastasis and effect of paraaortic lymphadenectomy on 5-year survival were evaluated. The overall incidences of pelvic and paraaortic lymph node involvement were 24.1% and 8.0%, respectively. The overall 5-year survival rate was 83.8%. The 5-year survival of patients subjected to both pelvic and paraaortic lymphadenectomy was found to be 84.6%; the figure was 80.9% for patients subjected to only pelvic lymphadenectomy. No statistical difference in survival was found between patients with and without paraaortic lymphadenectomy.

MeSH terms

  • Aorta, Abdominal
  • Female
  • Humans
  • Hysterectomy
  • Incidence
  • Lymph Node Excision*
  • Lymphatic Metastasis
  • Pelvis
  • Survival Analysis
  • Time Factors
  • Uterine Cervical Neoplasms / mortality*
  • Uterine Cervical Neoplasms / surgery